"a multifunctional point-of-care platform to differentiate HIV infection from vaccine induced seropositivity"
Active Definitive Contract Awarded Last action
- Contract number
- 75N93023C00006
- Awardee
-
Baebies, Inc. UEI NZSZBQ9B84T1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,299,994
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · SBIRPHS20231 · Posted Jul 20, 2022
- Contract value 100% obligated
- $2,299,994.00 Current and potential, with all options
- Completion date 77% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27703, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,999,995 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $299,999 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $2.3 million definitive contract to Baebies, Inc. for development of a multifunctional point-of-care platform to differentiate HIV infection from vaccine-induced seropositivity on August 1, 2023, under a total small business set-aside.
The originating solicitation was an NIAID Small Business Innovation Research pre-solicitation posted July 20, 2022, seeking Phase I and Phase II R&D contracts across research topics including infectious diseases. The platform development falls under NAICS 541711 or 541712 and carries firm-fixed-price terms.
Place of performance is Durham, NC. The contract extends to October 31, 2027. Through fiscal year 2024, Baebies invoiced $276 thousand across 2,095 contractor hours (1.0 FTEs) with no subcontractors, performing all work in-house.
Quick answers
Who was awarded contract 75N93023C00006?
75N93023C00006 was awarded to Baebies, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 26, 2023.
How much is contract 75N93023C00006 worth?
The government has obligated $2,299,994 on 75N93023C00006.
Was contract 75N93023C00006 competed?
The extent of competition for 75N93023C00006 was full and open competition after exclusion of sources. The government received 9 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award